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 Abstract 
Background: Recently, indocyanine green (ICG) fluorescence imaging has been reported 
as new method to detect sentinel lymph nodes (SLNs). However, high introduction costs 
limit its use. 
Objective: The purpose of this study was to construct an ICG fluorescence imaging 
system by using parts commonly available on the market, thereby reducing costs. 
Methods: We constructed this system using a charge-coupled device camera and 
light-emitting diodes. SLN biopsy using this system was performed in 16 patients with 
skin cancer.  
Results: We could construct our system at a cost of less than $1,600. This system could 
observe lymphatic channels through the skin and detect SLNs. However, SLNs in the 
neck were difficult to detect through the skin.  
Conclusion: Our system could be assembled at a reasonable cost and allowed us to 
detect SLNs efficiently. It may be used as an alternative to radiotracer for detecting 
SLNs located in the groin and axillary regions.  
Introduction 
 The concept of the sentinel lymph node (SLN) biopsy was first reported by Morton et 
al[1]. This method can avoid unnecessary lymphadenectomy for melanoma patients 
with negative SLN metastasis. Since that report, SLN biopsy has been widely used in 
the management of a variety of cancers, such as gastric cancer [2] and breast cancer [3].  
 SLN biopsy has been performed mainly using two different techniques: injection of 
blue dye (dye method) and injection of radioisotope colloid (RI method). Using blue dye 
is safe, convenient, and cost-effectiv, but the technique has certain limitations, such as a 
loss of visibility in dense fat and rapid transit of the dye[4], [5]. Thus, combined use of 
the dye and RI methods provides high rates of SLN detection: rates of over 90 % have 
been reported [6], [7]. However, some surgeons have voiced concern about the adverse 
effects of using radioactive agents both for the medical staff and the patient [8]. 
Moreover, handling of RI is strictly regulated and the intraoperative hand-held gamma 
probe system for SLN mapping is very expensive, costing approximately $20,000 [9]. 
Thus, legal, safety, and cost considerations limit the use of the RI method in general 
hospitals.  
 Recently, Kitai et al. [10] reported on the SLN biopsy technique using indocyanine 
green (ICG) fluorescence imaging in breast cancer patients. Unlike the blue dye, this 
ICG fluorescence penetrates human tissue to a depth of 1 to 2 cm and can detect the 
fluorescence transcutaneously in real time [11]. Although this ICG method would be of 
great benefit for hospitals where use of RI is not permitted, the ICG fluorescence 
detection system is very expensive, e.g., over $50,000 in Japan. Moreover, the surgery 
lamp should be turned off when detecting fluorescence because halogen lamps emit 
infrared light and ICG specific fluorescence cannot be detected. Repeatedly switching 
the lamp on and off leads to prolonged operation time. 
 In this study, we constructed an ICG fluorescence detection system (ICG-FDS) by 
using parts commonly available on the market to reduce costs and we compared the 
SLN detection rate with that of the conventional combined dye and RI method.  
  
Materials and Methods 
Instruments 
The excitation wavelength of ICG that produces maximum fluorescence is 765 nm, and 
the fluorescence occurs at 840 nm in plasma [12]. Accordingly, we used a light-emitting 
diode (LED) that generates 760-nm wavelength light as the excitation light, and a 
charge-coupled device (CCD) camera with a long-wavelength pass filter to filter out 
light with a wavelength below 840 nm as the detector. All the parts used in this 
ICG-FDS are listed in Table 1 For the construction of the ICD-FDS, we aligned 45 LEDs 
on a 75-mm diameter polyvinyl chloride (PVC) cap (Fig-1A). The CCD camera was set in 
the center of the cap. The main body consisted of a 75-mm diameter PVC pipe in the 
center of which we fixed the CCD camera (Fig-1B). The fluorescence image was sent to a 
TV monitor for real-time monitoring via a video recorder. When in use, the main body of 
the ICG-FDS was covered with a sterilized vinyl bag and the accessory cord, by a vinyl 
umbrella cover. We built this ICG-FDS at a cost of less than $1,600. 
To gain sufficient visible light intensity without altering the detecting fluorescence, we 
mounted a short-wavelength pass filter which passes below 810 nm onto a common 
headlight (Fig-1C)  
Before using this ICG-FDS in patients, we checked its performance by injecting ICG 
into the main author’s forearm (Fig-2A). Immediately after the injection, lymph vessels 
were detected as several lines projecting toward the axillary basin (Fig-2B and C). 
Finally, we could trace the lymph flow all the way to an axillary lymph node (Fig-2D).  
Procedure 
Before the operation, lymphoscintigraphy was performed. On the morning of the 
operation, 0.4 to 0.6 mL (4-6 MBq) of 99Tc- tin colloid (Japan Mediphisics, Tokyo, Japan) 
was intradermally injected around the primary tumor. The interval between injection of 
the tracer and earliest identification of a SLN varied from 5 to 20 minutes. Static 
images were taken and the skin overlying the detected SLN was marked before the 
patient was moved to the operation room. After the induction of general anesthesia, 0.3 
to 0.6 mL of 2% patent blue solution and 0.5% ICG (Diagnogreen ;, Dai-ichi 
Pharmaceutical, Tokyo, Japan) were intradermally injected around the primary tumor 
and ultrasonography was then performed to localize potential lymph nodes. Wearing 
the headlight mounted with the short-wavelength pass filter on his head, the operating 
surgeon manipulated the ICG-FDS to track the fluorescence (Fig-1C). It should be noted 
that the operation site was well lit (Fig-1D) Basically, the skin incision line was 
determined according to the result of the lymphoscintigraphy. For operations in which 
the RI method was not used, the incision line was determined according to the result of 
the ICG-FDS with ultrasonography support. An intraoperative gamma probe system 
(Navigator GPS System; RMD Instruments,Watertown, MA, USA) was also applied to 
detect the SLN.  
Patients 
Sixteen patients with skin cancer were examined from December 2009 to July 2010 at 
the Department of Dermatology of the University of Tsukuba Hospital. Of these, 6 had 
melanoma, 5 had extramammary Paget’ disease, 3 had squamous cell carcinoma, and 2 
had cutaneous adenocarcinoma. Informed consent was obtained from every patient.  
 
Results 
The results are shown in detail in Table 2. The SLNs were successfully identified in all 
16 patients, with 26 lymph node basins. The SLNs identified using the ICG-FDS were  
consistent with the results obtained by using the conventional methods: 95% using the 
RI method (19 in 20 lymph node basins) and 92% using the blue dye method (22 in 24 
lymph node basins). On average, the number of SLNs was 1.5 per basin on average (1-3). 
In 6 patients, the SLNs were in 2 lymph node basins; in 1 patient, they were in the 
axillae and groin; and in the other patients, they were in the bilateral groin. Four 
patients had metastatic SLNs and received lymph node dissection. 
In all cases, this ICG-FDS could detect the subcutaneous lymphatic stream (Fig-3A, B) 
flowing toward the lymph node basins and reached the SLN within 10 minutes. In 10 
patients, the lymph flow draining into the SLN could be detected through the skin with 
the ICG-FDS (Fig-3C, D). In 6 patients, the fluorescence could not be traced to the SLN 
owing to its deeper location; however, in 2 of these cases, we could improve the 
fluorescence observation by pushing or pulling the peripheral skin and reducing the 
depth of fluorescence (Fig 4A and B). This improvement could not be achieved in the 
other 4 because of the particular locations of the SLNs; under the primary tumor in 1 
case, in a parotid gland and under the sternocleidomastoid muscle in 1 case, under the 
platysma muscle in 1 case, and in the axillae in the other case. However, in these 4 
cases, the lymph channels could be observed after the skin incision, and the 
fluorescence to the SLN traced. 
In 3 cases, the results of the ICG method were inconsistent with those of conventional 
methods (underlined part in Table 2). In cases 2 and 14, the ICG and RI method 
identified the SLNs in the bilateral groin and submandibular region, respectively but 
failed to show accumulation of the blue dye. In case 7, lymphoscintigraphy identified 1 
SLN in the left groin, but the ICG method showed lymph flow toward the bilateral groin 
region (Fig. 4C and D). Both SLNs showed not only ICG but also blue dye accumulation. 
The reason for these discrepancies is uncertain, but we speculated that it might due to 
the difference of the injection sites, shorter interval between injection or lack of 
sufficient color intensity to permit identification. 
A spotlight with a pass filter provided sufficient light intensity for the SLN biopsy 
procedure without altering the fluorescence detection. This lighting reduced the 
operating time because the conventional ICG fluorescence method requires shutting 
down the surgical light each time fluorescence is being detected.  
 Discussion 
The concept of SLN biopsy is widely accepted in the management of various cancers, 
including breast, gastric, and skin cancers. However, this concept is based on accurate 
detection of the SLN, and false-negative SLN biopsy may lead to inappropriate 
assessment of the disease progression. The significance of the technical learning curve 
for SLN biopsy has been reported and substantial experience is required to develop the 
technical skill necessary to achieve a high success rate [4], [5]. The use of a 
radiopharmaceutical agent in addition to blue dye increased the success rate to 98% [4], 
but the use of radioisotopes is limited to large institutes and hospitals. Thus, a 
convenient, radioisotope-free, but reliable detection method is in great demand.  
ICG is a popular diagnostic reagent used in a variety of examinations, including hepatic 
function, cardiac output, and retinal angiography [10]. It binds with albumin to produce 
a peak wavelength of 840 nm near-infrared fluorescence when excitated with 765 nm 
light [12]. Thus, ICG can provide an ideal lymphatic tracer for SLN mapping because it 
shows high intensity and contrast compared with blue dye [13] and its near-infrared 
fluorescence penetrates human soft tissue and allows detection to a depth of 1 to 2 cm 
under the skin. We can easily observe the lymph flow in real time and the draining SLN. 
This real-time observation and visualization gives ICG its advantage over the handheld 
gamma probe method. Recently, several successful SLN biopsies using ICG fluorescence 
have been reported in breast cancer [10], [14] , gastric cancer [3], rectal cancer [15], and 
skin cancer [16].  
Since medical insurance in Japan does not cover the extra fee of SLN biopsy for skin 
malignancies other than melanoma, it is difficult for hospitals to purchase expensive 
medical electronic devices for SLN biopsy. Use of the handheld gamma probe system is 
gradually becoming common in various institutions because the combined use of the RI 
and blue dye methods is considered the standard method of SLN biopsy. However, few 
institutes have the extra budget needed to purchase an ICG detection system in 
addition to the RI method. The principle of ICG fluorescence imaging is very simple and 
we thought that we could construct an ICG detection system by using parts commonly 
available on the market. As a result, we could build a system with sufficient ability to 
detect fluorescence in the clinical setting and at a reasonable cost.  
On the other hand, the ICG fluorescence method has several limitations: (1) The 
maximum depth of detection is 2 cm from the surface of the skin. (2) ICG shows very 
high fluorescence intensity and just a small leak of ICG can contaminate the surgical 
field. (3) Quantitative evaluation of fluorescence is difficult at present. (4) A halogen 
surgical lamp contains over 840 nm of wavelength light and must be turned off during 
fluorescence detection. Each of these problems can be solved if the RI method is used in 
combination with the ICG fluorescence method. However, we assumed an RI-free 
situation and suggest the following solutions: for issues (1) and (2), use of preoperative 
ultrasonography and marking of potential lymph nodes. This marking helps to estimate 
the possible SLN location when the lymphatic channel cannot be traced through the 
skin as far as the draining SLN. Thus, the incision line can be drawn at the estimated 
SLN position and the risk of damaging unnecessary lymph channels reduced. However, 
the location of SLNs in the neck region varies and fluorescence is difficult to detect 
through the skin when the SLN is located in a salivary gland or under the muscle. If we 
perform ICG method alone, we cannot find the precise position of the SLN through the 
skin and we have to make a longer incision line to trace the lymph flow. Therefore, SLN 
mapping in the neck region still requires the RI method.  
The question of lighting has not been well discussed, but this is no small problem. The 
operation and fluorescence observation cannot be performed simultaneously under a 
conventional halogen lamp. Thus, repeated observation of fluorescence requires 
repeated lamp shutoff, which leads to extended operation time. On the other hand, our 
lighting system intercepts wavelength light of 810 nm or longer and provides sufficient 
light intensity for operating without affecting the detection of ICG fluorescence (Fig-1C 
and D). To the best of our knowledge, there has been no report of use of this type of light 
source. We suggest that using this system can be introduced very easily and will provide 
shorter operating time for SLN biopsy 
In conclusion, our ICG-FDS could be constructed at a reasonable cost and allowed us to 
visualize real-time lymph flow efficiently during surgery and to confirm the route of the 
lymph channels to the draining SLN SLN biopsy of the groin and axillae could be 
performed with this ICG-FDS combined with ultrasonography despite use of a 
radioactive agent Moreover, sufficient visible light intensity was obtained by using a 
light source with a short-wavelength pass filter concomitant with fluorescence detection. 
However, SLNs in the neck still require the RI method because lymph flow in this 
region varies and fluorescence is difficult to detect through the skin when drainage is 
into a node in a salivary gland or under the muscle. Despite such limitations, this 
system can be purchased at low cost and is easy to use. It may become a powerful 
method for detecting SLNs in the groin and axillary regions. However, owing to the 
limited number of patients enrolled in this study, further research is needed. 
 
This work was partly supported by a Management Expense Grants from the 
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Table 1  Parts used in ICD-FDS 
 
Parts name/parts no.  manufacturer   price(JP¥/US$) 
LED/L760-04AU  (50 LEDs) Ushio lighting, Tokyo, Japan      ¥29,000/$320 
CCD camera/ WAT-902H3 UL Watec, Yamagata, Japan  ¥37,000/$410 
Lens/ YF4A-SA2B  Fujinon, Tokyo, Japan  ¥8,000/$89 
TV monitor/ MG-1503J  G-force, Tokyo, Japan  ¥18,000/$200 
Power supply/ PBA30F  Cosel, Tokyo, Japan  ¥4,000/$45 
Long-pass filter/ LX840  Asahi spectra, Tokyo, Japan ¥18,000/$200 
Short-pass filter/ SIX810  Asahi spectra, Tokyo, Japan ¥18,000/$200 
MPEG encoder/ VR100  BitBay, Tokyo, Japan  ¥20,000/$222 
Others (connectors, cables,PVC tubes)    ¥15,000/$167 
Total   ¥138,000/$1534 
 
 
Table 2  Characteristics of the sixteen patients 
 
 
Pt     Primary tumor   SLN location   SLN detection   Identified SLN 
No.     / location  (*: meta(+))  through skin   Blue dye   RI   ICG 
1 AC/ lt lower abdomen  lt groin      ×   2  N.D    2 
2 SCC/ lt 5th toe  lt groin         ○   0   3    3 
3 AC/ rt mid abdomen  rt axilla      ○   2     2    2 
     rt groin      ○   1   1    1 
4 MM/ rt sole   rt groin      ○   1   1      1 
5 SCC/ vulva   rt groin*      ○   2   2    2 
     lt groin          ○   1       1    1 
6 MM/rt thumb  rt axilla      ○   1        1    1 
7 EMPD/ vulva  rt groin      ○   1   0    1 
     lt groin         ○   1    1    1 
8 MM/ lt temporal  lt retroauricular     ○   2   2    2 
      lt parotid      ×   1   1    1 
      lt mid-jugular      ×   1   1    1 
9 EMPD/ vulva   lt groin*         ○   1   N.D    1 
     rt groin*      ○   1  N.D    1 
10 EMPD/ scrotum      rt groin*      ○   2   2    2 
     lt groin          ○   1    1    1 
11 MM/ rt buttock  rt groin*          ○   3       N.D    3 
12 EMPD/ vulva  rt groin      ○   2   2    2 
     lt groin          ○   1   1    1 
13 MM/left hand  lt axilla      ○   2   1    2 
14  MM/ left nose  lt submandibular    ×   1   1     1 
     rt submandibular    ×   0    1    1 
15 EMPD/ vulva  lt groin       ○   2  2    2 
     rt groin      ○   1   1    1 
16 SCC/lt leg   lt groin       ○   1   1    1 
AC: adenocarcinoma, SCC: squamous cell carcinoma, MM: malignant melanoma, 
EMPD: extramammary Paget's disease, rt: right, lt: left, mid: middle, N.D: not done 
○: Yes, ×: No 
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